Cardiotoxicity as undesired side effect in the treatment of breast cancer
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue
Abstract
Improvement of methods used in breast cancer therapy resulted in increased treatment effectiveness and prolonged survival of patients. However, this is accompanied by increased frequency of adverse side effects, including cardiac toxicity, which is becoming a serious problem affecting the quality of life and overall survival of cancer patients. The risk of developing cardiovascular complications depends on the type and dose of therapeutic agent used. The highest risk of cardiotoxicity is associated with anthracyclines. They are used frequently in cancer therapy due to their high efficiency but show a dose-dependent toxicity to the cardiovascular system. Cardiotoxicity can also occur with other substances used in breast cancer chemotherapy, as well as with radiotherapy. Combining potentially cardiotoxic therapeutic agents, commonly used in combination therapy, may result in escalation of toxic side effects. Mechanisms of heart damage are different for various cardiotoxic agents, but symptoms usually involve heart failure, ischemic heart disease, arrhythmias, hypertension, valvular diseases or pericarditis and myocarditis. The practices used to reduce the risk of cardiotoxic effects of cancer therapy include evaluation of cardiac functions before treatment and constant monitoring during and after treatment. Furthermore, limited doses and modifications of anticancer agent administration patterns are employed, as well as simultaneous application of cardioprotective agents. Understanding of cardiotoxic mechanisms of agents used in breast cancer treatment can help to develop efficient cardioprotective substances. Because oxidative stress plays an important role in the toxicity of cancer therapy, compounds with antioxidant properties are a very promising target of research.
Authors and Affiliations
Michalina Gramatyka
Keywords
Related Articles
- EP ID EP67357
- DOI -
- Views 152
- Downloads 0
Salmonella multiphasic flagellar antigen
In the Salmonella antigenic pattern, more than one phase of flagellar antigen is observed. The phase of flagellar antigen depends of the gene which encodes the protein building the filament of flagella. The fliC gene en...
Rola białka YKL-40 w procesie nowotworowym
YKL-40 jest białkiem sekrecyjnym, wydzielanym m.in. przez komórki nowotworowe oraz makrofagi towarzyszące guzom. Ze względu na homologię strukturalną białko to zaklasyfikowano do rodziny chitynaz CLP (chitinase-like prot...
Molecular characteristic and physiological role of DOPA-decarboxylase
The enzyme DOPA decarboxylase (aromatic-L-amino-acid decarboxylase, DDC) plays an important role in the dopaminergic system and participates in the uptake and decarboxylation of amine precursors in the peripheral tissues...
Obecność Chlamydia pneumoniae a ekspresja wybranych cytokin w blaszce miażdżycowej krytycznie zwężonej tętnicy szyjnej
Diabetic microangiopathy in capillaroscopic examination of juveniles with diabetes type 1
Introduction: The aim of this work was a quantitative and qualitative assessment of a selected part of the microcirculation in children with diabetes type 1 using videocapillaroscopy technique. Material/Methods: The auth...